Buyout Buzz: Roche Snags $PSTX, $MYNZ in Focus$PSTX gets scooped up by Roche in a $1.5B acquisition, pricing shares near $9. This highlights the value of innovation in the space. $MYNZ, with its advanced test tech, might also attract M&A interest. A space worth monitoring for future moves.